Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression

INTRODUCTION: Arthralgias and myalgias are major side effects associated with aromatase inhibitor (AI) therapy of breast cancer. In a recent genome-wide association study, we identified SNPs - including one that created an estrogen response element near the 3' end of the T-cell leukemia 1A (TCL...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Liu, Mohan, Wang, Liewei, Bongartz, Tim, Hawse, John R, Markovic, Svetomir N, Schaid, Daniel J, Mushiroda, Taisei, Kubo, Michiaki, Nakamura, Yusuke, Kamatani, Naoyuki, Goss, Paul E, Ingle, James N, Weinshilboum, Richard M
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3446375/
https://ncbi.nlm.nih.gov/pubmed/22405131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3137
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars